title: [Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension].
abstract: Seventeen male untreated mild essential hypertensive patients with a mean age of 41 years agreed to participate in a double-blind randomized trial to test the effects of treatment with cilazapril, an inhibitor of angiotensin I converting enzyme, in comparison to treatment with atenolol, a beta-blocker, on the structure and function of subcutaneous resistance arteries. Patients were randomized to receive either cilazapril 2.5-5 mg or atenolol 25-100 mg per day per day. Blood pressure before treatment was 147/99 and 148/99 mmHg in both groups respectively. At 1 year of treatment blood pressure was 132/86 and 131/85 mmHg in both groups of patients respectively. Treatment for one year with cilazapril resulted in a reduction in the media/lumen ratio of resistance arteries (150-400 microns lumen diameter) dissected from subcutaneous gluteal biopsies from 7.5 +/- 0.3% before treatment to 6.3 +/- 0.2% 1 year later (p < 0.05), still slightly but significantly larger (p < 0.05) than the media/lumen ratio of resistance arteries of normotensive controls (5.1 +/- 0.3%). In arteries from patients treated with atenolol there was no significant change with treatment (8.0 +/- 0.6% before and 8.1 +/- 0.5% after 1 year of treatment). Active wall tension responses to endothelin-1 were blunted in hypertensive patients and normalized in the cilazapril-treated patients, but were unchanged in those taking atenolol. Relaxation in response to acetylcholine of norepinephrine pre-contracted arteries was still significantly reduced after one year (< 0.05) in comparison to those of normotensive patients in the patients treated with atenolol, whereas they were not in those who had received cilazapril.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institut de recherches cliniques de Montréal, Hôtel-Dieu de Montréal Université de Montréal, Québec, Canada.
authors.forename: E L
authors.initials: EL
authors.lastname: Schiffrin
authors.forename: L Y
authors.initials: LY
authors.lastname: Deng
authors.forename: P
authors.initials: P
authors.lastname: Larochelle
mesh_terms: D000328:Adult; D001158:Arteries / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D001262:Atenolol / Q000494:pharmacology*; D017315:Cilazapril / Q000494:pharmacology*; D002985:Clinical Protocols; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged
chemical_list: D017315:Cilazapril; D001262:Atenolol
vernacular_title: Essai prospectif des effets d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un bêtabloquant sur la structure et fonction des artères de résistance dans l'hypertension artérielle essentielle légère.